3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide, can be used in synthesis of novel dual-target compounds with antagonist/inverse agonist activity at cannabinoid receptor type 1 (CB1R) and inhibitory effect on inducible nitric oxide synthase (iNOS).

3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	19699	58

---

• 3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide
• 1H-Pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-4,5-dihydro-N'-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-
• (Rac)-MRI-1867
• (Rac)-Zevaquenabant
• 1610420-28-4
• C25H21ClF3N5O2S